| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191462 | European Journal of Surgical Oncology (EJSO) | 2015 | 7 Pages |
Abstract
Poor response, a residual tumor greater than 3Â cm and a fixed tumor are predictive of CRM+. Sphincter sparing is an oncological safety procedure for patients with 0-1 criteria but not for patients with 2-3 criteria.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Dumont, C. Tilly, P. Dartigues, D. Goéré, C. Honoré, D. Elias,